Kirin-Amgen, Inc. and Others v. Hoechst Marion Roussel Limited and Others
United Kingdom House of Lords
[2004] UKHL 46
- Written by Craig Conway, LLM
Facts
Kirin-Amgen, Inc. (“Amgen”) (plaintiff) obtained a patent for a process of producing erythropoietin (“EPO”) using recombinant DNA technology. Hoechst Marion Roussel Limited, Transkaryotic Therapies Inc., and others (collectively “TKT”) (defendant) developed a similar process using the same technology. Amgen brought suit against TKT for infringement. At the trial court, the judge construed the claim terms in a “literal” manner and then addressed the Protocol questions. The judge concluded that the TKT’s process did not infringe Amgen’s patent. The Court of Appeal affirmed and Amgen appealed.
Rule of Law
Issue
Holding and Reasoning (Hoffmann, L.)
What to do next…
Here's why 967,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 47,500 briefs, keyed to 1,007 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.
- AI-generated podcast version of every brief — listen on the go, between classes, or whenever reading isn’t an option. New
Understand your casebook readings in seconds
Use our case briefs to comprehend your casebook readings faster, supplement your notes and outlines, and outshine your peers in class.
Get instant access to over 47,500+ expert-written case briefs in a searchable database keyed to 1,007 law school casebooks.

